Default: Endocrine-Related Cancer

ISSN: 1351-0088

Journal Home

Journal Guideline

Endocrine-Related Cancer Q1 Unclaimed

BioScientifica Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Endocrine-Related Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 140. It has an SJR impact factor of 1,255 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,255.

Endocrine-Related Cancer focuses its scope in these topics and keywords: breast, phosphorylation, prostate, serine, paragangliomathe, metabolism, pathway, pheochromocytoma, pikaktmtor, receptor, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


Endocrine-Related Cancer


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

breast, phosphorylation, prostate, serine, paragangliomathe, metabolism, pathway, pheochromocytoma, pikaktmtor, receptor, response, sdhxrelated, steroid, survival, targeted, transcription, aspects, adjuvant, cancer, estrogen, cancerclinical, cancerlow, cancerstargeting, cancertamoxifen, castrationresistant, crosstalk, endocrine, erpositive, factor, growth, hormone, impact, improve, involvement,

Best articles by citations

Estrogen receptor beta in breast cancer.

View more

Combination hormonal therapy involving aromatase inhibitors in the management of women with breast cancer.

View more

Up-regulation of LRP16 mRNA by 17beta-estradiol through activation of estrogen receptor alpha (ERalpha), but not ERbeta, and promotion of human breast cancer MCF-7 cell proliferation: a preliminary report.

View more

Changes in neoplastic cell features and sensitivity to mitotane during mitotane-induced remission in a patient with recurrent, metastatic adrenocortical carcinoma.

View more

Molecular targets in breast cancer: current status and future directions.

View more

Identification and validation of cell surface antigens for antibody targeting in oncology

View more

Progress in breast cancer chemoprevention.

View more

A new form of familial multi-nodular goitre with progression to differentiated thyroid cancer

View more

Chipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer.

View more

Oestrogens and prostate cancer.

View more

Methylation mechanisms in pituitary tumorigenesis.

View more

Deregulated expression of selected histone methylases and demethylases in prostate carcinoma

View more

Proteomics study of serum exosomes from papillary thyroid cancer patients

View more

How to target estrogen receptor-negative breast cancer?

View more

Targeted radionuclide therapy for neuroendocrine tumours.

View more

BRCA1/2 carriers and endocrine risk modifiers.

View more

Quality of life and psychometric functionality in patients with differentiated thyroid carcinoma.

View more

Epigenetic change in pituitary tumorigenesis.

View more

Prostate cancer susceptibility genes: lessons learned and challenges posed.

View more

Serum oestradiol and breast cancer risk.

View more

Highlights of the biology of endocrine tumours of the gut and pancreas.

View more

Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors

View more

Chemoprevention of breast cancer and the trials of the National Surgical Adjuvant Breast and Bowel Project and others.

View more

The Krv¬?ppel-like transcription factor 6 gene in sporadic pituitary tumours.

View more